Absolute values of <i>M</i>₁ and <i>M</i>₂. by Tobit Führes (12647099)

“…Seven healthy volunteers underwent diffusion-weighted magnetic resonance imaging (DWI) with five diffusion encoding schemes (monopolar, velocity-compensated (<i>M</i>₁ = 0), acceleration-compensated (<i>M</i>₁ = <i>M</i>₂ = 0), 84%-<i>M</i>₁–<i>M</i>₂-compensated, 67%-<i>M</i>₁–<i>M</i>₂-compensated) at b-values of 50 and 800 s/mm² at a constant echo time of 70 ms. …”

Liver azoxystrobin residues after 1 and 2 months treatment with different doses of azoxystrobin on male rats. by Ekramy Halawa (11785086)

DNA methylation reprogramming of human cancer cells by expression of a plant 5-methylcytosine DNA glycosylase by Teresa Morales-Ruiz (4835973)

“…Unlike animals, plants possess enzymes that directly excise unoxidized 5mC from DNA, allowing restoration of unmethylated C through base excision repair. …”

FIGURE 3 from Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance by Debarshi Banerjee (17620899)

“…<p>Depletion of ATF5 induces anoikis and decreases metastasis of neuroblastoma cells. …”

Osteopontin activates the diabetes-associated potassium channel TALK-1 in pancreatic β-cells by Matthew T. Dickerson (3358280)

“…Twenty-one proteins from a human islet cDNA library interacted with TALK-1. Some of these interactions increased TALK-1 activity, including intracellular osteopontin (iOPN). …”

GIRK2^AgRP-KO mice show increased body weight and adiposity independently of food intake. by Youjin Oh (3308670)

Electrical properties of NPY neurons grouped by the response to tertiapin-Q. by Youjin Oh (3308670)

Death probability (%) of newly developed branches of persimmons according to the densities of <i>P</i>. <i>shantungensis</i> egg masses. by Sunghoon Baek (7042535)

<i>Srpr</i> is a direct target of miR-330-5p in mouse keratinocyte. by Bong-Kyu Kim (3235107)

“…(C) Real-time quantitative PCR showed that cotransfection of miR-330-5p and the full length SRPR-cDNA (<i>Srpr</i> CDS) was able to abolish the decreased expression of Srpr by miR-330-5p alone. …”

Data Sheet 7_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 6_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 1_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 3_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 5_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 2_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate by Jairo E. Perez-Franco (3166050)

“…<i>braziliensis</i> (95.4%) and 35% of the parasites isolated showed a significant decrease in <i>in vitro</i> Glucanatime susceptibility associated with previous administration of the medicament. …”

Primer utilisation patterns of the FMDV-5UTR forward primer using hot-start dNTPs. by Frank Vandenbussche (313767)

“…<p>Heat map of forward primer utilisation patterns using non-tailed (A and C) or tailed (B and D) primers. The heat map indicates the abundance of each primer variant for each FMDV isolate, with primers ordered by decreasing synthesis bias (A and B) or decreasing binding affinity (C and D). …”

Over-expression of LPLUNC1 inhibited the expression of MAPKs and their downstream molecules in 5-8F cells. by Yixin Yang (409184)

“…Immunohistochemical staining of components of the MAPK pathway in xenograft tumor tissues showed that LPLUNC1 decreased ERK, JNK, CDK4, c-MYC and c-JUN protein expression and increased p27 expression. …”